NGM Biopharmaceuticals Inc (was acquired by Atlas Neon Parent, Inc. on 05/04/2024) (NGM) Event Oct. 17, 2022, 11:40 UTC 28 1 comments (10% Negative) NGM BIOPHARMACEUTICALS INC (NGM) Announces Delay in reduction Development Timeline Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Decibel Therapeutics Inc (was acquired Regeneron Pharmaceuticals Inc (REGN)) (DBTX) Event Oct. 17, 2022, 11:39 UTC 26 1 comments (99% Neutral) Decibel Therapeutics, Inc. (DBTX) Announces Clinical Development Update Comment Full text
Mereo BioPharma (MREO) Event Oct. 17, 2022, 11:16 UTC 19 1 comments (75% Positive) Mereo BioPharma (MREO) Announces Clinical Development Update (Form 6-K) Comment Full text
Abcam Plc (ABCM) Event Oct. 17, 2022, 10:19 UTC 19 1 comments (10% Negative) Abcam Plc (ABCM) Announces 2022 Annual General Meeting Comment Full text
9 Meters Biopharma Inc. (NMTR) Event Oct. 17, 2022, 06:20 UTC 111 0 comments 9 Meters Biopharma Announces 1-for-20 Reverse Stock Split Comment Full text
Mereo BioPharma (MREO) Event Oct. 17, 2022, 05:05 UTC 103 0 comments Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat for Treatment of Alpha-1 Antitrypsin Deficiency (AATD)-associated Lung Disease Comment Full text
Syneos Health (was acquisited by consortium of private investment firm affiliates composed of Elliott Investment Management L.P. on 28/09/2023) (SYNH) Event Oct. 14, 2022, 20:55 UTC 23 1 comments (99% Neutral) SYNEOS HEALTH, INC. (SYNH) Announces New Board Appointment Comment Full text
Brooklyn ImmunoTherapeutics Inc (the company was transformed Eterna Therapeutics (ERNA)) (BTX) Event Oct. 14, 2022, 20:33 UTC 23 1 comments (99% Neutral) Brooklyn ImmunoTherapeutics, Inc. (BTX) Announces Business Combination Comment Full text
RedHill Biopharma (RDHL) Event Oct. 14, 2022, 20:30 UTC 19 1 comments (19% Negative) RedHill Biopharma (RDHL) Announces Clinical Development Update (Form 6-K) Comment Full text
Tcr2 Therapeutics Inc (the company was acquired by Adaptimmune Therapeutics plc (NASDAQ: ADAP)) (TCRR) Event Oct. 14, 2022, 20:17 UTC 58 1 comments (99% Neutral) TCR2 THERAPEUTICS INC. (TCRR) Files Form 8-K Comment Full text